The bile acid receptor TGR5 and cholestasis
暂无分享,去创建一个
[1] I. Leclercq,et al. Enterohepatic Takeda G-Protein Coupled Receptor 5 Agonism in Metabolic Dysfunction-Associated Fatty Liver Disease and Related Glucose Dysmetabolism , 2022, Nutrients.
[2] R. Fiorotto,et al. Bile acids and their receptors: modulators and therapeutic targets in liver inflammation , 2022, Seminars in Immunopathology.
[3] C. Sempoux,et al. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice , 2021, JHEP reports : innovation in hepatology.
[4] J. Rao,et al. Corrigendum to: Deficiency of TGR5 exacerbates immune-mediated cholestatic hepatic injury by stabilizing the β-catenin destruction complex , 2021, International Immunology.
[5] Haojun Yang,et al. TGR5 protects against cholestatic liver disease via suppressing the NF-κB pathway and activating the Nrf2/HO-1 pathway , 2021, Annals of translational medicine.
[6] T. Luedde,et al. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis. , 2021, Journal of hepatology.
[7] F. Tacke,et al. Circulating Bile Acids in Liver Failure Activate TGR5 and Induce Monocyte Dysfunction , 2021, Cellular and molecular gastroenterology and hepatology.
[8] Shan Hu,et al. Activation of TGR5 restores AQP2 expression via HIF pathway in renal ischemia/reperfusion injury. , 2021, American journal of physiology. Renal physiology.
[9] R. Boisgard,et al. TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload , 2020, JHEP reports : innovation in hepatology.
[10] J. C. Wolters,et al. Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid , 2020, Cellular and molecular gastroenterology and hepatology.
[11] M. Itoh,et al. The zonula occludens protein family regulates the hepatic barrier system in the murine liver. , 2020, Biochimica et biophysica acta. Molecular basis of disease.
[12] B. Cummings,et al. TGR5 Signaling in Hepatic Metabolic Health , 2020, Nutrients.
[13] John H. Zhang,et al. Correction to: Activation of TGR5 protects blood brain barrier via the BRCA1/Sirt1 pathway after middle cerebral artery occlusion in rats , 2020, Journal of Biomedical Sciences.
[14] J. Chiang,et al. Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease. , 2020, Hepatobiliary surgery and nutrition.
[15] T. Tordjmann,et al. Hepatoprotective impact of the bile acid receptor TGR5 , 2020, Liver international : official journal of the International Association for the Study of the Liver.
[16] Y. Bao,et al. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. , 2020, Cell metabolism.
[17] Lingpeng Zhu,et al. TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] H. Nakauchi,et al. Vasoactive Intestinal Peptide Derived From Liver Mesenchymal Cells Mediates Tight Junction Assembly in Mouse Intrahepatic Bile Ducts , 2019, Hepatology Communications.
[19] Yan Yang,et al. Gentiopicroside activates the bile acid receptor Gpbar1 (TGR5) to repress NF-kappaB pathway and ameliorate diabetic nephropathy (original article). , 2019, Pharmacological research.
[20] Satoru Takahashi,et al. Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition[S] , 2019, Journal of Lipid Research.
[21] A. Carino,et al. Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.
[22] J. C. Wolters,et al. A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice[S] , 2019, Journal of Lipid Research.
[23] H. Jaeschke,et al. INFLAMMATION AND CELL DEATH DURING CHOLESTASIS: THE EVOLVING ROLE OF BILE ACIDS. , 2019, Gene expression.
[24] Yi-horng Lee,et al. FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury. , 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[25] S. V. D. van de Graaf,et al. Developments in bile salt based therapies: A critical overview , 2019, Biochemical pharmacology.
[26] Baolei Jia. Commentary: Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells , 2019, Front. Immunol..
[27] T. Tordjmann,et al. TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function , 2019, Gut.
[28] M. Zerial,et al. Claudin-3 regulates bile canalicular paracellular barrier and cholesterol gallstone core formation in mice. , 2018, Journal of hepatology.
[29] C. Borchers,et al. Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2−/− mice[S] , 2018, Journal of Lipid Research.
[30] D. Häussinger,et al. Role of TGR5 (GPBAR1) in Liver Disease , 2018, Seminars in Liver Disease.
[31] K. Kodys,et al. FXR and TGR5 Agonists Ameliorate Liver Injury, Steatosis, and Inflammation After Binge or Prolonged Alcohol Feeding in Mice , 2018, Hepatology communications.
[32] T. Kwon,et al. Bile Acid G Protein-Coupled Membrane Receptor TGR5 Modulates Aquaporin 2-Mediated Water Homeostasis. , 2018, Journal of the American Society of Nephrology : JASN.
[33] Simon C Watkins,et al. Dysregulated Bile Transporters and Impaired Tight Junctions During Chronic Liver Injury in Mice. , 2018, Gastroenterology.
[34] F. Gonzalez,et al. Intestine farnesoid X receptor agonist and the gut microbiota activate G‐protein bile acid receptor‐1 signaling to improve metabolism , 2018, Hepatology.
[35] Simon C Watkins,et al. Dual catenin loss in murine liver causes tight junctional deregulation and progressive intrahepatic cholestasis , 2018, Hepatology.
[36] Junichi Ikenouchi,et al. Regulation of the epithelial barrier by post-translational modifications of tight junction membrane proteins. , 2018, Journal of biochemistry.
[37] M. Hayden,et al. Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[38] S. Glaser,et al. Mechanisms of cholangiocyte responses to injury. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[39] T. Tordjmann,et al. Bile acids and their receptors during liver regeneration: "Dangerous protectors". , 2017, Molecular aspects of medicine.
[40] J. Boyer,et al. Mechanisms of bile acid mediated inflammation in the liver. , 2017, Molecular aspects of medicine.
[41] D. Francisci,et al. The Bile Acid Receptor GPBAR1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis , 2017, The Journal of Immunology.
[42] Hui Qi,et al. The G-protein-coupled bile acid receptor Gpbar1 (TGR5) protects against renal inflammation and renal cancer cell proliferation and migration through antagonizing NF-κB and STAT3 signaling pathways. , 2017, Oncotarget.
[43] F. Gonzalez,et al. Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis. , 2017, Cell metabolism.
[44] D. Jain,et al. Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response. , 2017, JCI insight.
[45] J. Chiang,et al. G‐protein‐coupled bile acid receptor plays a key role in bile acid metabolism and fasting‐induced hepatic steatosis in mice , 2017, Hepatology.
[46] H. Hsu,et al. Prognostic roles of tetrahydroxy bile acids in infantile intrahepatic cholestasis[S] , 2017, Journal of Lipid Research.
[47] J. Hampe,et al. The ascending pathophysiology of cholestatic liver disease , 2017, Hepatology.
[48] P. Chiba,et al. Metabolic preconditioning protects BSEP/ABCB11-/- mice against cholestatic liver injury. , 2017, Journal of hepatology.
[49] Yingwei Chen,et al. Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis , 2016, Oncotarget.
[50] C. Brocker,et al. Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans[S] , 2016, Journal of Lipid Research.
[51] Dustin E. Schones,et al. Vertical sleeve gastrectomy activates GPBAR‐1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice , 2016, Hepatology.
[52] D. Xia,et al. Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome. , 2016, Immunity.
[53] Yingjie Yu,et al. The G-Protein-Coupled Bile Acid Receptor Gpbar1 (TGR5) Inhibits Gastric Inflammation Through Antagonizing NF-κB Signaling Pathway , 2015, Front. Pharmacol..
[54] R. Ley,et al. TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice , 2015, Gut.
[55] D. Häussinger,et al. TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro , 2015, Gut.
[56] T. Tordjmann,et al. The Bile Acid Receptor TGR5 and Liver Regeneration , 2015, Digestive Diseases.
[57] Richard J. Thompson,et al. Mutations in TJP2, encoding zona occludens 2, and liver disease , 2015, Tissue barriers.
[58] T. Tordjmann,et al. Bile acids and FGF receptors: orchestrators of optimal liver regeneration , 2015, Gut.
[59] N. Schmiedeberg,et al. G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) agonists reduce the production of proinflammatory cytokines and stabilize the alternative macrophage phenotype. , 2014, Journal of medicinal chemistry.
[60] C. V. Van Itallie,et al. Architecture of tight junctions and principles of molecular composition. , 2014, Seminars in cell & developmental biology.
[61] K. Schoonjans,et al. TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation. , 2014, The Journal of clinical investigation.
[62] S. Werner,et al. Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice , 2014, Gut.
[63] J. Boyer. The hepatobiliary paracellular pathway: a paradigm revisited. , 2014, Gastroenterology.
[64] H. Eguchi,et al. Claudin 2 deficiency reduces bile flow and increases susceptibility to cholesterol gallstone disease in mice. , 2014, Gastroenterology.
[65] B. Harvey,et al. Bile acids stimulate chloride secretion through CFTR and calcium-activated Cl- channels in Calu-3 airway epithelial cells. , 2014, American journal of physiology. Lung cellular and molecular physiology.
[66] L. Adorini,et al. Semisynthetic Bile Acid FXR and TGR5 Agonists: Physicochemical Properties, Pharmacokinetics, and Metabolism in the Rat , 2014, The Journal of Pharmacology and Experimental Therapeutics.
[67] W. Naugler. Bile Acid Flux Is Necessary for Normal Liver Regeneration , 2014, PLoS ONE.
[68] D. Herranz,et al. SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling , 2014, Hepatology.
[69] Xi Chen,et al. Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids. , 2014, Cancer research.
[70] T. Murata,et al. Stimulation of G Protein–Coupled Bile Acid Receptor Enhances Vascular Endothelial Barrier Function via Activation of Protein Kinase A and Rac1 , 2014, The Journal of Pharmacology and Experimental Therapeutics.
[71] V. Ling,et al. Hepatic bile acid metabolism and expression of cytochrome P450 and related enzymes are altered in Bsep−/− mice , 2014, Molecular and Cellular Biochemistry.
[72] B. Bhushan,et al. GASTROINTESTINAL , HEPATOBILIARY , AND PANCREATIC PATHOLOGY Role of Bile Acids in Liver Injury and Regeneration following Acetaminophen Overdose , 2013 .
[73] T. Tordjmann,et al. The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice , 2013, Hepatology.
[74] Yu-Chung Wu,et al. Bile acids increase alveolar epithelial permeability via mitogen‐activated protein kinase, cytosolic phospholipase A2, cyclooxygenase‐2, prostaglandin E2 and junctional proteins , 2013, Respirology.
[75] N. Lambert,et al. The Bile Acid Receptor TGR5 Does Not Interact with β-Arrestins or Traffic to Endosomes but Transmits Sustained Signals from Plasma Membrane Rafts* , 2013, The Journal of Biological Chemistry.
[76] N. LaRusso,et al. Ciliary subcellular localization of TGR5 determines the cholangiocyte functional response to bile acid signaling. , 2013, American journal of physiology. Gastrointestinal and liver physiology.
[77] T. Berg,et al. Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrier. , 2013, Gastroenterology.
[78] R. Tavares,et al. Expression of bile acid receptor TGR5 in gastric adenocarcinoma. , 2013, American journal of physiology. Gastrointestinal and liver physiology.
[79] S. Morini,et al. Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice , 2013, Gut.
[80] M. Rietkerk,et al. Bile salts predict liver regeneration in rabbit model of portal vein embolization. , 2012, The Journal of surgical research.
[81] R. Chamuleau,et al. Can Plasma Bile Salt, Triglycerides, and apoA-V Levels Predict Liver Regeneration? , 2012, World Journal of Surgery.
[82] P. Dawson,et al. Defects in gallbladder emptying and bile Acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies. , 2012, Gastroenterology.
[83] D. Cassio,et al. Claudin‐1 involved in neonatal ichthyosis sclerosing cholangitis syndrome regulates hepatic paracellular permeability , 2012, Hepatology.
[84] A. Suzuki,et al. aPKC phosphorylates JAM-A at Ser285 to promote cell contact maturation and tight junction formation , 2012, The Journal of cell biology.
[85] M. Trauner,et al. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis. , 2012, Gastroenterology.
[86] S. Catalano,et al. Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances Cyclin D1 expression and promotes human endometrial cancer cell proliferation , 2012, Cell cycle.
[87] C. Paulusma,et al. A biliary HCO3− umbrella constitutes a protective mechanism against bile acid‐induced injury in human cholangiocytes , 2012, Hepatology.
[88] J. Auwerx,et al. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. , 2011, Cell metabolism.
[89] G. Bifulco,et al. The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis , 2011, PloS one.
[90] B. M. Forman,et al. The G‐Protein‐coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light‐chain enhancer of activated B cells (NF‐κB) in mice , 2011, Hepatology.
[91] A. Baghdasaryan,et al. Dual farnesoid X receptor/TGR5 agonist INT‐767 reduces liver injury in the Mdr2−/− (Abcb4−/−) mouse cholangiopathy model by promoting biliary HCO 3− output , 2011, Hepatology.
[92] J. Auwerx,et al. The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. , 2011, Journal of hepatology.
[93] S. Kliewer,et al. The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling. , 2011, Molecular endocrinology.
[94] D. Samuel,et al. Immediate neuroendocrine signaling after partial hepatectomy through acute portal hyperpressure and cholestasis. , 2011, Journal of hepatology.
[95] K. Zilles,et al. The bile acid receptor TGR5 (Gpbar‐1) acts as a neurosteroid receptor in brain , 2010, Glia.
[96] D. Häussinger,et al. The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes , 2010, Biological chemistry.
[97] U. Beuers,et al. Bile salts and cholestasis. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[98] H. Pan,et al. FXR regulates liver repair after CCl4-induced toxic injury. , 2010, Molecular endocrinology.
[99] Jie Hong,et al. Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma , 2009, Gut.
[100] J. Auwerx,et al. TGR5-mediated bile acid sensing controls glucose homeostasis. , 2009, Cell metabolism.
[101] D. Häussinger,et al. The membrane‐bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders , 2009, Hepatology.
[102] C. Klaassen,et al. Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[103] C. V. Van Itallie,et al. Physiology and function of the tight junction. , 2009, Cold Spring Harbor perspectives in biology.
[104] Johan Auwerx,et al. Targeting bile-acid signalling for metabolic diseases , 2008, Nature Reviews Drug Discovery.
[105] D. Häussinger,et al. Expression and function of the bile acid receptor TGR5 in Kupffer cells. , 2008, Biochemical and biophysical research communications.
[106] Stacy A. Johnson,et al. Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis , 2008, Hepatology.
[107] C. Apicella,et al. Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[108] J. Auwerx,et al. Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. , 2008, Journal of medicinal chemistry.
[109] N. LaRusso,et al. Cholangiocyte cilia express TRPV4 and detect changes in luminal tonicity inducing bicarbonate secretion , 2007, Proceedings of the National Academy of Sciences.
[110] Hiroshi Yasuda,et al. Involvement of membrane-type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-activated protein kinases in gastric carcinoma cells. , 2007, Biochemical and biophysical research communications.
[111] M. Trauner,et al. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. , 2007, Biochimica et biophysica acta.
[112] D. Häussinger,et al. The G‐protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells , 2007, Hepatology.
[113] H. Miyoshi,et al. Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice. , 2006, The Journal of endocrinology.
[114] H. Davis,et al. Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation. , 2006, The Biochemical journal.
[115] D. Moore,et al. Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration , 2006, Science.
[116] K. Zatloukal,et al. Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice. , 2006, The American journal of pathology.
[117] A. Smahi,et al. Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease. , 2004, Gastroenterology.
[118] R. Taub. Liver regeneration: from myth to mechanism , 2004, Nature Reviews Molecular Cell Biology.
[119] H. Tilg,et al. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. , 2004, Gastroenterology.
[120] D. Häussinger,et al. Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. , 2003, Gastroenterology.
[121] Masataka Harada,et al. A G Protein-coupled Receptor Responsive to Bile Acids* , 2003, The Journal of Biological Chemistry.
[122] Takao Nakamura,et al. Identification of membrane-type receptor for bile acids (M-BAR). , 2002, Biochemical and biophysical research communications.
[123] F. Di Virgilio,et al. Proinflammatory cytokines inhibit secretion in rat bile duct epithelium. , 2001, Gastroenterology.
[124] T. Kawaguchi,et al. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis , 2001, Hepatology.
[125] R. Sokol,et al. Bile acid‐induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition , 2001, Hepatology.
[126] F. Carubbi,et al. Review article: effect of bile salt pool composition on hepatic and biliary functions , 2000, Alimentary pharmacology & therapeutics.
[127] G. Gores,et al. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. , 1999, Gastroenterology.
[128] B. Stieger,et al. Structure-function correlation of tight junctional impairment after intrahepatic and extrahepatic cholestasis in rat liver. , 1996, Gastroenterology.